Skip to main content
Clinical Trials/NCT06631001
NCT06631001RecruitingNot Applicable

The Effect of Abdominal Massage on Gastrointestinal Functions in Mechanically Ventilated Patients Receiving Enteral Nutrition in Intensive Care

Mersin University1 site in 1 country70 target enrollmentStarted: January 6, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
70
Locations
1
Primary Endpoint
Bowel Movements: This measure will assess the frequency of defecation during the intervention period.

Study Overview

Brief Summary

This study aims to evaluate the effects of abdominal massage on gastrointestinal functions in mechanically ventilated patients receiving enteral nutrition in intensive care units.

Detailed Description

Intensive care units (ICUs) are areas where advanced technologies and multidisciplinary care are provided together to sustain and treat critically ill patients. Patients treated in the ICU due to reasons such as inadequate gas exchange, increased respiratory workload, and inability to maintain airway patency are intubated and placed on mechanical ventilation support. ICU patients dependent on mechanical ventilators become reliant on external nutrition during the treatment process as they cannot meet their nutritional needs. In ICU patients, damage to the digestive mucosa due to stress may occur, leading to various gastrointestinal (GI) problems such as increased residual volume, diarrhea, constipation, and malnutrition. Therefore, providing accurate and adequate nutritional support is critically important in the treatment processes of ICU patients. In recent years, nutritional support has been included among therapeutic methods in ICUs. Studies have shown that appropriately timed nutritional support positively affects the clinical outcomes of patients in intensive care units. Enteral or parenteral nutrition methods can be chosen based on the patient's health status and guidelines.

For ICU patients on mechanical ventilator support, if the gastrointestinal tract is functional, enteral nutrition is frequently preferred. Enteral nutrition is the delivery of nutrients to the stomach or small intestine via a tube, catheter, or stoma. Enteral nutrition is a commonly used method for patients who cannot eat orally. It can reduce infection risk, shorten catabolic responses, the formation of gastric ulcers, and the length of hospital stay. Starting enteral nutrition within the first 48 hours for patients admitted to the ICU has been reported to shorten hospital stay and reduce mortality rates.

Although enteral nutrition has high physiological response rates, there are also risks and potential side effects. The most common GI complications encountered in patients receiving enteral nutrition are gastrointestinal complications. GI complications in enteral nutrition are influenced by many factors, including the patient's general condition, mechanical ventilation, hemodynamic parameters, and administered medications. These complications include aspiration, diarrhea, constipation, abdominal distension, and nausea/vomiting. These side effects have been observed in 62% of patients receiving this type of nutrition. Constipation is a digestive system complication that is often overlooked in ICU patients. Immobility, hypotension, the use of vasopressors and narcotics, and lack of access to appropriate conditions and facilities are among the reasons for constipation development. Constipation prolongs the duration of mechanical ventilation and increases the length of stay in ICUs. In a study evaluating enteral nutrition complications, 48.5% of the patients experienced dislodgement of their nasogastric tube, 45.5% had electrolyte imbalances, 34.5% developed hyperglycemia, 32.8% had diarrhea, 29.7% experienced constipation, 20.4% had vomiting, and 3.1% developed pulmonary aspiration.Another study found that 32% of ICU patients receiving enteral nutrition experienced increased gastric residual volume, while 46% developed gastrointestinal intolerance.

GI problems encountered in ICUs can be prevented, reduced, and patient comfort can be increased through pharmacological and non-pharmacological treatments (abdominal massage, aromatherapy, acupuncture, mobilization, etc.). A study investigating nutrition and motility issues in ICUs found that non-pharmacological methods, alongside pharmacological approaches, were also emphasized, with abdominal massage applied in 39% of cases to address motility problems. Non-pharmacological methods have various advantages over pharmacological approaches. The most important advantage of these methods is that they can be easily applied to individuals. Additionally, they offer a more cost-effective solution in terms of both patient and hospital costs.

Abdominal massage, which aims to stimulate and increase intestinal peristalsis, is performed by applying effleurage, petrissage, and vibration techniques clockwise on the abdomen for 15-20 minutes. Abdominal massage, performed by nurses, caregivers, or family members, is a safe, non-invasive method with no known side effects. This massage has been shown to be effective for those experiencing defecation issues, abdominal pain caused by gas or cramps, individuals with altered abdominal muscle tone, and those suffering from fecal incontinence or chronic constipation. Studies evaluating the effectiveness of abdominal massage in preventing GI complications in ICUs are relatively limited. A study found that abdominal massage was effective in reducing constipation and improving quality of life.A study on patients receiving enteral nutrition in neurology and neurosurgery clinics stated that abdominal massage could be used to prevent abdominal distension and increased gastric residual volume (GRV). According to a study conducted in Germany, it was reported that abdominal massage began to be used to improve GI complications in 38.8% of ICU patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

This study is single-blind, meaning that participants are unaware of whether they are in the intervention or control group, while care providers and investigators have access to this information.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients over 18 years of age.
  • •Patients who have been intubated and are on enteral feeding for at least 5 days.
  • •Patients without wounds on the extremities or abdominal area.
  • •Patients without a history of surgical intervention or radiotherapy in the abdominal area.
  • •Patients without current gastrointestinal symptoms (constipation, diarrhea, vomiting, abdominal distension, or increased gastric residual volume).
  • •Patients without intestinal obstruction.
  • •Patients who have given consent through a first-degree relative.
  • •Patients with no contraindications for abdominal massage.
  • •Glasgow Coma Scale GCS >
  • •Acute Physiology and Chronic Health Evaluation (APACHE II) score > 16

Exclusion Criteria

  • •Patients receiving intermittent enteral nutrition
  • •Patients not on mechanical ventilation
  • •Patients with contraindications for abdominal massage
  • •Patients fed via Percutaneous Endoscopic Gastrostomy
  • •Patients who were intubated later
  • •Patients hospitalized due to postoperative reasons

Arms & Interventions

Abdominal Massage Group

Experimental

This group consists of patients receiving abdominal massage. Abdominal massage will be administered twice a day for 15 minutes. This intervention is conducted to assess its effects on defecation frequency, gastric residual volume, and abdominal distension.

Intervention: Abdominal Massage (Other)

Control Group

No Intervention

This group will receive standard care without abdominal massage. Measurements for bowel excretion frequency, gastric residual volume, and abdominal distension will also be conducted.

Outcomes

Primary Outcomes

Bowel Movements: This measure will assess the frequency of defecation during the intervention period.

Time Frame: Measured twice daily (morning and evening) over 3 days.

he frequency of bowel movements will be recorded to assess gastrointestinal function, where increased frequency is considered a positive outcome.

Secondary Outcomes

  • This measure will be used to determine the amount of stomach content remaining after feeding.(Measured twice daily (morning and evening) over 3 days.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

YUSUF YÜCE

master student nurse

Mersin University

Study Sites (1)

Loading locations...

Similar Trials